Catalent to sell Somerset oral solids facility
Catalent (NYSE:CTLT) is selling its oral solids development and small-scale manufacturing facility in Somerset, New Jersey to ...
Business Insider1mon
Ardena Completes Acquisition of Advanced Drug Product Manufacturing Facility from Catalent and Expands Bioanalytical Services in North America
today announced that it has successfully completed the acquisition of Catalent’s state-of-the-art drug product manufacturing facility in Somerset, New Jersey. This acquisition marks a ...
Nasdaq17d
Catalent Announces New Board Appointments
SOMERSET, N.J.--(BUSINESS WIRE)-- Catalent, Inc., the leader in enabling the development and supply of better treatments for patients worldwide, today announced that it has appointed Susan Mahony ...
manilatimes1mon
Ardena Completes Acquisition of Advanced Drug Product Manufacturing Facility from Catalent and Expands Bioanalytical Services in North America
today announced that it has successfully completed the acquisition of Catalent's state-of-the-art drug product manufacturing facility in Somerset, New Jersey. This acquisition marks a significant ...